← Eichor
Study identifier: NCT06841913 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Condition: Smoke Exposure · Influenza  ·  Sponsor: University of North Carolina, Chapel Hill

PhasePhase 4
Planned participants112
Who can joinAll sexes, 18 Years to 49 Years
Healthy volunteersYes

About this study

This study will investigate the effects of woodsmoke (WS) exposure on human nasal mucosal immune responses to viral infection. The study tests the hypotheses that WS exposure modifies biomarkers of nasal mucosal immune function, increases in Live Attenuated Influenza Virus (LAIV) -induced nasal symptoms, and reduces mucosal antibody production.

This description comes directly from the study's public registry record.

Talk to the study team

Carole Robinette, MS  ·  919 966-5638  ·  carole_robinette@med.unc.edu

Chris Brooks  ·  chris_brooks@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mary Ellen JonesChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06841913